PTH has been used for the treatment of various types of liver inflammation and tumor for more than ten decades, and the present study revealed that PTH protects against LCA-induced cholestatic liver injury, as evidenced by improved liver morphology and histology, as well as a significant decrease in the serum ALT/AST/ALP and serum total BAs. This evidence concerns the gene PTH and neoplasm.